Incidence and Severity of Weight Gain Associated with the Use of Olanzapine for the Treatment of Schizophrenia
![]() |
Lee, Kyung-Hee
(Graduate School of Clinical Pharmacy, Yeungnam University)
Shanmugam, Srinivasan (College of Pharmacy, Yeungnam University) Baskaran, Rengarajan (College of Pharmacy, Yeungnam University) Nagayya-Sriraman, Santhoshkumar (College of Pharmacy, Yeungnam University) Yong, Chul-Soon (College of Pharmacy, Yeungnam University) Choi, Han-Gon (College of Pharmacy, Yeungnam University) Woo, Jong-Soo (College of Pharmacy, Yeungnam University) Yoo, Bong-Kyu (College of Pharmacy, Yeungnam University) |
1 | Chengappa, K., Pollock, B., Parepally, H., Levine, J., Kirshner, M., Brar, J. and Zoretich, R. : Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine. J. Clin. Psychopharmacol. 20, 311 (2000) DOI ScienceOn |
2 | Isaac, M. and Isaac, M. : Olanzapine and weight gain. Am. J. Psychiatry 162, 1764 (2005) DOI ScienceOn |
3 | Smith, E., Rothschild, A., Heo, M., Peasley-Miklus, C., Caswell, M., Papademetriou, E., Flint, A., Mulsant, B. and Meyers, B. : Weight gain during olanzapine treatment for psychotic depression: effects of dose and age. Int. Clin. Psychopharmacol. 23, 130 (2008) DOI ScienceOn |
4 | Fleischhaker, C., Heiser, P., Hennighausen, K., Herpertz- Dahlmann, B., Holtkamp, K., Mehler-Wex, C., Rauh, R., Remschmidt, H., Schulz, E. and Warnke, A. : Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents. J. Neural. Transm. 114, 273 (2007) DOI PUBMED ScienceOn |
5 |
Eli Lilly and Company. |
6 | Mulsant, B., Gharabawi, G., Bossie, C., Mao, L., Martinez, R., Tune, L., Greenspan, A., Bastean, J. and Pollock, B. : Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine. J. Clin. Psychiatry 65, 1708 (2004) DOI PUBMED ScienceOn |
7 | http://lawprofessors.typepad.com/mass_tort_litigation/zyprexa/ index.html (accessed on May 8, 2008) |
8 | Lipkovich, I., Citrome, L., Perlis, R., Deberdt, W., Houston, J., Ahl, J. and Hardy, T. : Early predictors of substantial weight gain in bipolar patients treated with olanzapine. J. Clin. Psychopharmacol. 26, 316 (2006) DOI ScienceOn |
9 | Matza, L., Baker, T. and Revicki, D. : Efficacy of olanzapine and ziprasidone for the treatment of schizophrenia: a systematic review. CNS Drugs 19, 499 (2005) DOI ScienceOn |
10 | Lund, B. and Perry, P. : Olanzapine: an atypical antipsychotic for schizophrenia. Expert Opin. Pharmacother. 1, 305 (2000) DOI ScienceOn |
11 | Kinon, B., Kaiser, C., Ahmed, S., Rotelli, M. and Kollack- Walker, S. : Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders. J. Clin. Psychopharmacol. 25, 255 (2005) |
12 | McClellan, J. : Olanzapine and pediatric bipolar disorder: evidence for efficacy and safety concerns. Am. J. Psychiatry 164, 1462 (2007) DOI ScienceOn |
13 | http://www.symbyax.com/prescribing/consumer_safety.jsp (accessed on May 8, 2008) |
14 | Yatham, L., Goldstein, J., Vieta, E., Bowden, C., Grunze, H., Post, R., Suppes, T. and Calabrese, J. : Atypical antipsychotics in bipolar depression: potential mechanisms of action. J. Clin. Psychiatry 66(Suppl 5), 40 (2005) PUBMED |
15 | Strawn, J. and Delbello, M. : Olanzapine for the treatment of bipolar disorder in children and adolescents. Expert Opin. Pharmacother. 9, 467, (2008) DOI ScienceOn |
16 | Ketter, T., Houston, J., Adams, D., Risser, R., Meyers, A., Williamson, D. and Tohen, M. : Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes. J. Clin. Psychiatry 67, 95, (2006) DOI ScienceOn |
17 | Bhana, N., Foster, R., Olney, R. and Plosker, G. : Olanzapine: an updated review of its use in the management of schizophrenia. Drugs 61, 111 (2001) DOI ScienceOn |
18 | Meyer, J. : A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year. J. Clin. Psychiatry 63, 425 (2002) DOI PUBMED ScienceOn |
![]() |